Your browser doesn't support javascript.
loading
Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
Corren, Jonathan; Pham, Tuyet-Hang; Garcia Gil, Esther; Salapa, Kinga; Ren, Pin; Parnes, Jane R; Colice, Gene; Griffiths, Janet M.
Afiliação
  • Corren J; David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
  • Pham TH; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Garcia Gil E; Global Medical Respiratory, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain.
  • Salapa K; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland.
  • Ren P; Early Biostats and Statistical Innovation, Early-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Parnes JR; Translational Medicine, Amgen, Thousand Oaks, California, USA.
  • Colice G; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Griffiths JM; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Allergy ; 77(6): 1786-1796, 2022 06.
Article em En | MEDLINE | ID: mdl-34913186
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Interleucina-5 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Interleucina-5 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos